2022-02-11 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Medical Officer | 928 0.0027% | $1.53 | $1,420 | -21.79% | |
2020-07-01 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 2,142 0.0084% | $18.30 | $39,199 | -33.42% | |
2020-06-25 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 2,918 0.0074% | $13.41 | $39,145 | -48.23% | |
2020-06-10 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 802 0.0024% | $13.41 | $10,759 | -39.91% | |
2020-06-05 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 902 0.004% | $20.18 | $18,202 | -39.34% | |
2020-06-04 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 452 0.0012% | $12.44 | $5,623 | -42.43% | |
2020-06-03 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 676 0.0029% | $20.18 | $13,639 | -41.91% | |
2020-06-02 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 90 0.0002% | $12.41 | $1,117 | -41.58% | |
2020-05-29 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 400 0.0008% | $10.02 | $4,007 | -41.49% | |
2020-05-28 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 1,200 0.0026% | $10.00 | $12,000 | -39.18% | |
2020-05-12 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 3,720 0.0119% | $11.41 | $42,464 | -20.72% | |
2020-03-02 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 4,286 0.0182% | $17.38 | $74,510 | -33.64% | |
2020-02-03 | Sale | Fulcrum Therapeutics, Inc. FULC | SVP Clinical Development | 4,286 0.0191% | $17.33 | $74,284 | -29.67% |